Synopsis
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Book Details
ISBN-13 :
9783319668338
Publisher :
Springer International Publishing, Cham
Date of Addition:
2018-10-24T00:50:25Z
Language :
eng
Categories :
Business and Finance
,
Medicine
,
Nonfiction
,
Politics and Government
,
BUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology
,
MEDICAL / Pharmacology
,
POLITICAL SCIENCE / World / European
Usage Restrictions:
Copyright.